Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation

References

• Porter C, Trevaskis N, Charman W. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Dics 2007;6:231–48
   PubMed Web of Science ®Google Scholar
• Gao X, Bhattacharya S, Chan WK, et al. Expression of P-glycoprotein and CYP3A4 along the porcine oral-gastrointestinal tract: implications on oral mucosal drug delivery. Drug Dev Ind Pharm 2014;40:599–603
   PubMed Web of Science ®Google Scholar
• Narang A, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007;345:9–25
   PubMed Web of Science ®Google Scholar
• Song A, Su Z, Li S, et al. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.959021
   Google Scholar
• Muller R, Petersen R, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59:522–30
   PubMed Web of Science ®Google Scholar
• Dabholkar RD, Sawant RM, Mongayt DA, et al. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 2006;315:148–57
   PubMed Web of Science ®Google Scholar
• Malhotra HS, Goa KL. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. Drug 2001;61:1835–81
   PubMed Web of Science ®Google Scholar
• Poli A. Atorvastatin: pharmacological characteristics and lipid lowering effects. Drugs 2007;67:3–15
   PubMed Web of Science ®Google Scholar
• Khan FN, Dehghan MH. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation. AAPS PharmSciTech 2011;12:1077–86
   PubMed Web of Science ®Google Scholar
• Breitkreitz MC, Sabin GP, Polla G, et al. Characterization of semi-solid Self-Emulsifying Drug Delivery Systems (SEDDS) of atorvastatin calcium by Raman image spectroscopy and chemometrics. J Pharm Biomed Anal 2013;73:3–12
   PubMed Web of Science ®Google Scholar
• Choudharya A, Ranaa AC, Aggarwalb G, et al. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharmaceutica Sinica B 2012;2:421–8
   Google Scholar
• Hochman JH, Yamazaki M, Ohe T, Lin JH. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein. Curr Drug Metab 2002;3:257–73
   PubMed Web of Science ®Google Scholar
• Huang L, Wang Y, Grimm S. ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein. Drug Metab Dispos 2006;34:738–42
   PubMed Web of Science ®Google Scholar
• Lacerda SP, Espitalier F, Hoffart V, et al. Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug. Drug Dev Ind Pharm 2015. [Epub ahead of print]. doi:10.3109/03639045.2015.1020812
   Google Scholar
• Arunkumar N, Deecaraman M, Rani C, et al. Preparation and solid state characterization of atorvastatin nanosuspensions for enhanced solubility and dissolution. Int J Pharm Tech Res 2009;1:1725–30
   Google Scholar
• Anwar M, Warsi MH, Mallick N, et al. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats. Eur J Pharm Sci 2011;44:241–9
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, Cho WK, et al. Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers. Int J Biol Macromol 2013;59:138–42
   Google Scholar
• Mattila P, Kumpulainen J. Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. J Agric Food Chem 2002;50:3660–7
   PubMed Web of Science ®Google Scholar
• Nardini M, Aquino MD, Tomassi G, et al. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biomed Med 1995;19:542–52
   Web of Science ®Google Scholar
• Watanabe T, Arai Y, Mitsui Y, et al. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens 2006;28:439–49
   PubMed Web of Science ®Google Scholar
• Wan CW, Wong CN, Pin WK, et al. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. Phytother Res 2013;27:545–51
   PubMed Web of Science ®Google Scholar
• Mullen W, Nemzer B, Ou B, et al. The antioxidant and chlorogenic acid profiles of whole coffee fruits are influenced by the extraction procedures. J Agric Food Chem 2011;59:3754–62
   PubMed Web of Science ®Google Scholar
• Altuntas TG, Erk N. Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma. J Liq Chrom Relat Tech 2004;27:83–93
   Web of Science ®Google Scholar
• Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces 2010;76:410–20
   PubMed Web of Science ®Google Scholar
• Kadu PJ, Kushare SS, Thacker DD, Gattani SG. Enhancement of oral bioavailability of atorvastatin calcium by Self-Emulsifying Drug Delivery Systems (SEDDS). Pharm Dev Technol 2011;16:65–74
   PubMed Web of Science ®Google Scholar
• Shete H, Patravale VS. Long chain lipid based tamoxifen NLC. Part I: preformulation, formulation development and physicochemical characterization. Int J Pharm 2013;454:573–83
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao L, Almasy L, et al. Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations. Int J Pharm 2013;450:225–34
   PubMed Web of Science ®Google Scholar
• Zhuang C, Li N, Wanga M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 2010;394:179–85
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release 2006;114:53–9
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Zhang YI, et al. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci 2011;43:174–9
   PubMed Web of Science ®Google Scholar
• Muller RH, Gohla S, Keck CM. State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm 2011;78:1–9
   PubMed Web of Science ®Google Scholar
• Black AE, Hayes RN, Roth BD, et al. Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos 1999;27:916–23
   PubMed Web of Science ®Google Scholar
• Watanabe K, Bois FY, Zeise L. Interspecies extrapolation: a reexamination of acute toxicity data. Risk Anal 1992;12:301–10
   PubMed Web of Science ®Google Scholar
• Freireich EJ, Gehan EA, Rall DP, et al. Quantitative comparission of toxicity of anti-cancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 1996;50:219–44
   Google Scholar
• Shen HR, Zhong MK. Preparation and evaluation of self-microemulsifying drug delivery system (SMEDDS) containing atorvastatin. Pharm Pharmacol 2006;58:1183–91
   PubMed Web of Science ®Google Scholar
• Chaudhari HS, Bhandari U, Khanna G. Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. Planta Med 2012;78:651–7
   PubMed Web of Science ®Google Scholar
• Muhlen A, Muhlen E, Niehus H, et al. Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res 1996;13:1411–16
   PubMed Web of Science ®Google Scholar
• Dolatabadi JEN, Hamishehkar H, Valizadeh H. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.956111
   Google Scholar
• Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 2011;415:232–43
   PubMed Web of Science ®Google Scholar
• Kumbhar DD, Pokharkar VB. Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: physicochemical investigations. Colloids Surf A 2013;416:32–42
   Web of Science ®Google Scholar
• SAAPedia. Available from: http://www.saapedia.org [last accessed 7 Jul 2014]
   Google Scholar
• Sasaki K, Alamed J, Weiss J, et al. Relationship between the physical properties of chlorogenic acid esters and their ability to inhibit lipid oxidation in oil-in-water emulsions. Food Chem 2010;118:830–5
   Web of Science ®Google Scholar
• Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61:115–25
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Müller RH, et al. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement. Drug Dev Ind Pharm 2011;37:8–14
   PubMed Web of Science ®Google Scholar
• Khurana S, Jain NK, Bedi PMS. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation. Drug Dev Ind Pharm 2014. [Epub ahead of print]. DOI: 10.3109/03639045.2014.950586
   Google Scholar
• Tso P. Intestinal lipid absorption. In: Johnson LR, ed. Physiology of the gastrointestinal tract. New York: Raven Press; 1994:1867–907
   Google Scholar
• Porter CJH, Charman WN. Transport and absorption of drugs via lymphatic system. Adv Drug Deliv Rev 2001;50:61–80
   PubMed Web of Science ®Google Scholar
• Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 2004;284:109–22
   PubMed Web of Science ®Google Scholar
• Najar IA, Sachin BS, Sharma SC, et al. Modulation of P-glycoprotein ATPase activity by some phytoconstituents. Phytother Res 2010;24:454–8
   PubMed Web of Science ®Google Scholar
• Chen C, Tsai TH, Huang ZR, et al. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 2010;74:474–82
   PubMed Web of Science ®Google Scholar
• Li SY, Chang CQ, Ma FY, Yu CL. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-α in golden hamsters fed on high fat diet. Biomed Environ Sci 2009;22:122–9
   PubMed Web of Science ®Google Scholar